Stock Message Board Recent Posts http://investorshangout.com/search?q=NONOF&am...mp;yt0=Go!
Last Updated: 08/02/2014 18:41:37
Current Price and Quotes
Last Price 44.70
Previous Close 45.61 Open 44.61
Daily Range N/A - 44.70 52wk Range 35.65 - 185.05
Volume 156 Dividend N/A
Average Vol (3m) 8,308 Yield N/A
Financials
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue 13,788,000 11,588,000
Cost of Revenue 2,379,000 2,199,000
Gross Profit 11,408,000 9,389,000
Operating Expenses
Research and Development 1,926,000 1,682,000
Sales, General and Admin. 4,274,000 3,800,000
Non-Recurring Items - -
Other - -
Operating Income 5,208,000 3,908,000
Income From Continuing Operations
Add'l Income/Expense Items 22,000 90,000
Earnings Before Interest and Tax 5,230,000 3,997,000
Interest Expense 316,000 168,000
Earnings Before Tax 4,914,000 3,829,000
Income Tax 1,127,000 843,000
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations 3,787,000 2,986,000
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income 3,787,000 2,986,000
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders 3,787,000 2,986,000
Recent News
Jul 28, 2014 Novo Nordisk A/S - Share repurchase programme
Jul 25, 2014 Novo Nordisk A/S: Novo Nordisk receives positive opinion on Xultophy(r) (IDegLira) from the European regulatory authorities
Jul 22, 2014 Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com
Jul 18, 2014 Global Type 1 Diabetes Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Co, Novo Nordisk and Sanofi-Aventis
Jul 17, 2014 Health Care Sector Stocks Technical Review: Valeant Pharma, Teva Pharma Industries, Novo Nordisk, Curis, and Amarin
Jul 14, 2014 CORRECTION: Novo Nordisk A/S: Novo Nordisk A/S - Share repurchase programme
Jul 14, 2014 Novo Nordisk A/S: Share repurchase programme
Jul 7, 2014 FDA Approves NovoSeven® RT for the Treatment of Glanzmann's Thrombasthenia (GT) With Refractoriness
Jul 7, 2014 Novo Nordisk's Insulin Degludec/Liraglutide is Set to Become the Clinical Gold-Standard Among Fixed-Dose Combination Therapies for Type 2 Diabetes
Jul 1, 2014 Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (30 June 2014)
1
2
3
4
next >
NONOF Novo-Nordisk A/S Research DD Guide
Stock Message Board http://investorshangout.com/search?q=NONOF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/NONOF/quote
Stock Chart http://www.otcmarkets.com/stock/NONOF/chart
Company Info http://www.otcmarkets.com/stock/NONOF/company-info
Recent News http://www.otcmarkets.com/stock/NONOF/news
Financials http://www.otcmarkets.com/stock/NONOF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/NONOF/filings
Short Sales http://www.otcmarkets.com/stock/NONOF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/NONOF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/NONOF/research
Summary http://finance.yahoo.com/q?s=NONOF
Historical Prices http://finance.yahoo.com/q/hp?s=NONOF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=NONOF
Basic Chart http://finance.yahoo.com/q/bc?s=NONOF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NONOF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=NONOF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=NONOF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=NONOF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=NONOF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=NONOF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=NONOF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=NONOF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=NONOF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=NONOF
Balance Sheet http://finance.yahoo.com/q/bs?s=NONOF
Cash Flow http://finance.yahoo.com/q/cf?s=NONOF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/NONOF
Market Watch http://www.marketwatch.com/investing/stock/NONOF
Bloomberg http://www.bloomberg.com/quote/NONOF:US
Morningstar http://quotes.morningstar.com/stock/s?t=NONOF
Bussinessweek http://investing.businessweek.com/research/st...cker=NONOF
Barchart http://www.barchart.com/quotes/stocks/NONOF
OTC Short Report http://otcshortreport.com/index.php?index=NONOF
Investopedia http://www.investopedia.com/markets/stocks/NONOF/?wa=0